An observational long-term safety and efficacy followup study after ex-vivo gene therapy with BIVV003 inparticipants with severe sickle cell disease (SCD) orwith ST-400 in participants with transfusion-dependent??-thalassemia (TDT) with autologous hem

Project: Research project

Project Details

Description

An observational long-term safety and efficacy followup study after ex-vivo gene therapy with BIVV003 in participants with severe sickle cell disease (SCD) or with ST-400 in participants with transfusion-dependent ??-thalassemia (TDT) with autologous hem
StatusActive
Effective start/end date7/21/217/31/26

Funding

  • SANOFI-AVENTIS US

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.